|
Eli Lilly and Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$987
|
$966B |
15.2x |
33.5x |
|
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$242
|
$612B |
6.5x |
17.1x |
|
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$232
|
$472B |
7.7x |
18.1x |
|
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$122
|
$327B |
5.0x |
11.0x |
|
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$375
|
$247B |
6.8x |
14.0x |
|
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$155
|
$210B |
7.2x |
13.1x |
|
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$27
|
$197B |
3.2x |
8.0x |
|
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$61
|
$160B |
3.3x |
8.6x |
|
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$491
|
$120B |
10.0x |
22.2x |
|
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$127
|
$60.4B |
6.4x |
14.7x |
|
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$16
|
$31.7B |
2.2x |
7.7x |
|
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$197
|
$31.6B |
3.2x |
10.4x |
|
Royalty Pharma
|
United States of America |
Biopharmaceuticals
|
$45
|
$26.8B |
9.0x |
9.2x |
|
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$128
|
$11.8B |
4.1x |
17.8x |
|
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$79
|
$10.2B |
7.6x |
11.6x |
|
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$7
|
$10.1B |
1.6x |
5.2x |
|
Praxis Precision Medicines
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$317
|
$8.5B |
28552.0x |
-28.7x |
|
Amneal Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$15
|
$7.1B |
2.4x |
10.5x |
|
Belite Bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$174
|
$6.2B |
N/A |
N/A |
|
Cogent Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$37
|
$5.4B |
N/A |
-20.0x |
|
Celcuity
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$107
|
$4.8B |
N/A |
-29.1x |
|
Scholar Rock
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$46
|
$4.5B |
N/A |
-11.3x |
|
Alkermes
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$33
|
$4.4B |
3.0x |
11.7x |
|
Terns Pharma
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$40
|
$4.0B |
N/A |
-35.7x |
|
ADMA Biologics
|
United States of America |
Biopharmaceuticals
|
$16
|
$3.9B |
7.5x |
16.4x |
|
Erasca
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$12
|
$3.5B |
N/A |
-24.2x |
|
NewAmsterdam Pharma Co
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$35
|
$3.3B |
120.7x |
-15.7x |
|
Kiniksa Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$45
|
$3.1B |
4.6x |
28.9x |
|
Arcutis Biotherapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$26
|
$3.1B |
8.6x |
-1609.5x |
|
Alumis
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$27
|
$3.0B |
119.6x |
-12.2x |
|
Spyre Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$37
|
$2.7B |
N/A |
-12.7x |
|
Alvotech
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$5
|
$2.7B |
4.6x |
20.4x |
|
Supernus Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$51
|
$2.7B |
3.8x |
21.0x |
|
Travere Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$28
|
$2.6B |
5.2x |
290.1x |
|
Tarsus Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$63
|
$2.4B |
5.3x |
-37.2x |
|
Ascentage Pharma
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$24
|
$2.3B |
30.6x |
-17.1x |
|
WAVE Life Sciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$13
|
$2.2B |
51.8x |
-10.8x |
|
ANI Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$77
|
$2.1B |
2.4x |
9.2x |
|
Harrow
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$51
|
$2.0B |
7.5x |
28.9x |
|
Collegium Pharmaceutical
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$46
|
$2.0B |
2.5x |
4.3x |
|
Maze Therapeutics
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Digital Therapeutics
|
$45
|
$1.8B |
N/A |
-12.9x |
|
Galecto
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$29
|
$1.7B |
N/A |
N/A |
|
Amphastar Pharma
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$28
|
$1.7B |
2.3x |
6.4x |
|
Oculis Holding
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$29
|
$1.7B |
1628.8x |
-16.4x |
|
Dianthus Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$47
|
$1.6B |
724.3x |
N/A |
|
Arcus Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals,
Vaccines & Immunotherapies
|
$19
|
$1.6B |
6.6x |
-4.5x |
|
Aurinia Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$14
|
$1.6B |
5.7x |
10.8x |
|
Ardelyx
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$7
|
$1.6B |
4.0x |
-379.4x |
|
Mineralys Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$28
|
$1.6B |
N/A |
-9.3x |
|
Tango Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$12
|
$1.6B |
24.7x |
-14.5x |
|
Stoke Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$31
|
$1.5B |
8.1x |
138.3x |
|
Disc Medicine
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$56
|
$1.5B |
N/A |
-6.4x |
|
Zymeworks
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$23
|
$1.5B |
12.3x |
-28.8x |
|
Olema Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$23
|
$1.5B |
N/A |
-8.8x |
|
Nuvation Bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$6
|
$1.5B |
26.9x |
N/A |
|
Sionna Therapeutics
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$38
|
$1.4B |
N/A |
-16.1x |
|
Innoviva
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$23
|
$1.4B |
3.6x |
6.1x |
|
MBX Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$39
|
$1.4B |
N/A |
-14.0x |
|
Pharvaris
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$26
|
$1.3B |
N/A |
-7.0x |
|
Syndax
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$20
|
$1.3B |
7.8x |
-5.0x |
|
Xeris Biopharma
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$7
|
$1.3B |
4.5x |
24.6x |
|
Ironwood Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$5
|
$1.2B |
4.1x |
8.2x |
|
Tyra Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$28
|
$1.2B |
N/A |
-9.4x |
|
Zenas BioPharma
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$27
|
$1.1B |
39.3x |
-5.6x |
|
Enliven Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$26
|
$1.1B |
128828.1x |
-9.4x |
|
Phathom Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$13
|
$1.1B |
6.2x |
-7.7x |
|
Savara
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$6
|
$1.0B |
N/A |
N/A |
|
Esperion Therapeutics
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$3
|
$1.0B |
2.6x |
39.3x |
|
Relay Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$9
|
$1.0B |
80.2x |
-3.2x |
|
Emergent BioSolutions
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$11
|
$986M |
1.2x |
4.9x |
|
UroGen Pharma
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$21
|
$966M |
8.5x |
-8.2x |
|
Sana Biotechnology
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$4
|
$955M |
N/A |
-4.7x |
|
OPKO Health
|
United States of America |
Biopharmaceuticals,
Medical Imaging & Diagnostics
|
$1
|
$924M |
1.5x |
-6.8x |
|
Evommune
|
United States of America |
Biopharmaceuticals
|
$32
|
$919M |
70.7x |
-11.8x |
|
Rapport Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$28
|
$830M |
N/A |
-7.1x |
|
Septerna
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Small Molecules
|
$28
|
$817M |
20.9x |
-13.1x |
|
Nika Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
$1
|
$786M |
N/A |
N/A |
|
Day One Biopharmaceutical
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$12
|
$771M |
5.2x |
-6.3x |
|
Arbutus Biopharma
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$4
|
$728M |
53.4x |
N/A |
|
ORIC Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$10
|
$699M |
N/A |
-4.8x |
|
ArriVent BioPharma
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$23
|
$660M |
N/A |
-4.3x |
|
Annexon
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$5
|
$567M |
N/A |
-2.5x |
|
Bioage Labs
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$20
|
$541M |
76.7x |
-6.0x |
|
Lexicon Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$1
|
$492M |
10.4x |
-8.0x |
|
Bicara Therapeutics
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$14
|
$483M |
N/A |
-3.2x |
|
Armata Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$8
|
$460M |
101.0x |
-14.8x |
|
Elite Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$0
|
$452M |
N/A |
N/A |
|
Xencor
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$12
|
$422M |
3.3x |
-2.6x |
|
Cullinan Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$12
|
$389M |
63.5x |
-1.7x |
|
Contineum Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$15
|
$379M |
75.8x |
-5.5x |
|
Altimmune
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$5
|
$372M |
59588.4x |
-4.1x |
|
Procaps Group
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
$0
|
$331M |
N/A |
N/A |
|
CytoDyn
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$0
|
$330M |
N/A |
N/A |
|
SIGA Technologies
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$7
|
$315M |
3.2x |
10.8x |
|
Climb Bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$6
|
$302M |
N/A |
-4.9x |
|
Forte Biosciences
|
United States of America |
Biopharmaceuticals
|
$30
|
$280M |
N/A |
N/A |
|
Anavex Life Sciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$4
|
$232M |
4.2x |
N/A |
|
Protalix
|
United States of America |
Biopharmaceuticals
|
$3
|
$218M |
3.5x |
N/A |
|
OmniAb
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$2
|
$208M |
10.8x |
-4.9x |
|
LENZ Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$13
|
$207M |
10.9x |
-2.6x |